Perceval Sutureless valve is now embarked on 1200 pt worldwide study to compare it with standard sutured valve
Major milestone as patients needing open aortic valve replacement benefit from easier-to-implant prosthesis
Sorin’s newly announced study is first international prospective RCT to compare its TAVR offering with traditional replacement valve
Study will evaluate whether response to cardiac resynchronization therapy (CRT) may be improved in selected heart failure patients through Tri-V pacing.
Sorin’s Sutureless Valve is in the process of undergoing U.S. FDA approval, but in the meantime is beefing up its international presence with the go-ahed in another market
Tiny device offers patient benefit of minimal size combined with functionality including sleep apnea monitoring
Solo Smart offers the superior hemodynamics of a stentless valve combined with a stented valve’s ease of implantation
Sorin’s sutureless aortic valve demonstrates improved outcome compared with TAVR in medium-high risk patients and favorable outcomes in every day surgery
Sorin Group has gained Japanese regulatory approval for its new KORA 100 pacing system with automatic magnetic resonance imaging mode
Sorin has gained U.S. FDA clearance for Memo 3D ReChord™, an innovative semi-rigid annuloplasty ring for mitral valve repair.
Can CRT optimization using SonR heart sensor improve outcome in heart failure patients? A significant study, now fully enrolled, should tell us.
Sorin Group has gained CE mark certification for its new MEMO 3D ReChord™ mitral valve annuloplasty ring, which it is making immediately available in Europe.
Sorin Group has announced that it is to make a $20 million minority investment in Respicardia, a developer of implantable therapies to improve Respiratory Rhythm Management™.
Sorin Group is touting the results of the European and North American (Canada and US) cohort study on the Freedom Solo valve.
Sorin Group has announced the results of the Perceval CAVALIER Trial and of the Pooled European Multicenter Experience at this week’s 28th EACTS Congress
The first U.S. implantation of Sorin’s Solo Smart aortic valve represents a first removable stent valve procedure in the country.